305 related articles for article (PubMed ID: 19476611)
1. Varicella vaccination in Europe - taking the practical approach.
Bonanni P; Breuer J; Gershon A; Gershon M; Hryniewicz W; Papaevangelou V; Rentier B; Rümke H; Sadzot-Delvaux C; Senterre J; Weil-Olivier C; Wutzler P
BMC Med; 2009 May; 7():26. PubMed ID: 19476611
[TBL] [Abstract][Full Text] [Related]
2. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
[TBL] [Abstract][Full Text] [Related]
3. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
4. Varicella in Europe-A review of the epidemiology and experience with vaccination.
Helmuth IG; Poulsen A; Suppli CH; Mølbak K
Vaccine; 2015 May; 33(21):2406-13. PubMed ID: 25839105
[TBL] [Abstract][Full Text] [Related]
5. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.
Prymula R; Bergsaker MR; Esposito S; Gothefors L; Man S; Snegova N; Štefkovičova M; Usonis V; Wysocki J; Douha M; Vassilev V; Nicholson O; Innis BL; Willems P
Lancet; 2014 Apr; 383(9925):1313-1324. PubMed ID: 24485548
[TBL] [Abstract][Full Text] [Related]
6. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial.
Povey M; Henry O; Riise Bergsaker MA; Chlibek R; Esposito S; Flodmark CE; Gothefors L; Man S; Silfverdal SA; Štefkovičová M; Usonis V; Wysocki J; Gillard P; Prymula R
Lancet Infect Dis; 2019 Mar; 19(3):287-297. PubMed ID: 30765242
[TBL] [Abstract][Full Text] [Related]
7. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
[TBL] [Abstract][Full Text] [Related]
8. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
[TBL] [Abstract][Full Text] [Related]
9. Consensus: varicella vaccination of healthy children--a challenge for Europe.
Rentier B; Gershon AA;
Pediatr Infect Dis J; 2004 May; 23(5):379-89. PubMed ID: 15131459
[TBL] [Abstract][Full Text] [Related]
10. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
[TBL] [Abstract][Full Text] [Related]
11. Varicella vaccination in Japan, South Korea, and Europe.
Sadzot-Delvaux C; Rentier B; Wutzler P; Asano Y; Suga S; Yoshikawa T; Plotkin SA
J Infect Dis; 2008 Mar; 197 Suppl 2():S185-90. PubMed ID: 18419395
[TBL] [Abstract][Full Text] [Related]
12. One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
Henry O; Brzostek J; Czajka H; Leviniene G; Reshetko O; Gasparini R; Pazdiora P; Plesca D; Desole MG; Kevalas R; Gabutti G; Povey M; Innis B
Vaccine; 2018 Jan; 36(3):381-387. PubMed ID: 29224964
[TBL] [Abstract][Full Text] [Related]
13. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
[TBL] [Abstract][Full Text] [Related]
14. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.
Casabona G; Berton O; Singh T; Knuf M; Bonanni P
Expert Rev Vaccines; 2023; 22(1):764-776. PubMed ID: 37642012
[TBL] [Abstract][Full Text] [Related]
15. Implementing Universal Varicella Vaccination in Europe: The Path Forward.
Spoulou V; Alain S; Gabutti G; Giaquinto C; Liese J; Martinon-Torres F; Vesikari T
Pediatr Infect Dis J; 2019 Feb; 38(2):181-188. PubMed ID: 30408002
[TBL] [Abstract][Full Text] [Related]
16. A combination vaccine against measles, mumps, rubella and varicella.
Knuf M; Faber J; Barth I; Habermehl P
Drugs Today (Barc); 2008 Apr; 44(4):279-92. PubMed ID: 18536786
[TBL] [Abstract][Full Text] [Related]
17. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
Nolan T; McIntyre P; Roberton D; Descamps D
Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
[TBL] [Abstract][Full Text] [Related]
18. Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U.
Scott LJ
Paediatr Drugs; 2015 Apr; 17(2):167-74. PubMed ID: 25732634
[TBL] [Abstract][Full Text] [Related]
19. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
Ramet J
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S49-55. PubMed ID: 18162247
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
